Condition
Respiratory Syncytial Virus clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Respiratory Syncytial Virus clinical trials that are recruiting, at sites in 6 countries (most in United Kingdom (2), Australia (1), South Korea (1)). By phase: Phase 2 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 6Countries
Newest Respiratory Syncytial Virus clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| RSV+HMPV protein shot for adults 60 and older | Phase 2 | Bruse, Australian Capital Territory and 20 other locations | Recruiting | Sep 9, 2026 |
| Real-world safety monitoring of Beyfortus (nirsevimab) in Korean infants and toddlers | — | Hwaseong-si, Gyeonggi-do | Recruiting | Oct 1, 2025 |
| Evaluating a new vaccine for Respiratory Syncytial Virus | Phase 1/2 | Langfang, Hebei and 1 other locations | Recruiting | Jan 1, 2025 |
| Antiviral treatment for early RSV symptoms | Phase 2 | Vientiane and 1 other locations | Recruiting | Jul 5, 2024 |
| Examining the impact of COVID-19 on RSV-related emergency visits in children | — | Leicester | Recruiting | Jul 13, 2021 |
All recruiting trials (5)
-
RSV+HMPV protein shot for adults 60 and older
A single shot of a two-virus vaccine is being tested in adults 60+ to see if it can prevent RSV and hMPV infections compared with placebo.
-
Real-world safety monitoring of Beyfortus (nirsevimab) in Korean infants and toddlers
This program follows children up to 24 months in Korea who receive Beyfortus to see if the medicine is safe when used in routine care.
-
Evaluating a new vaccine for Respiratory Syncytial Virus
This study is testing a new vaccine for Respiratory Syncytial Virus (RSV) in adults to see how safe it is and how well it helps the immune system.
-
Antiviral treatment for early RSV symptoms
This trial will test whether antiviral drugs—ribavirin, molnupiravir, or favipiravir—can lower viral levels and help adults 18–64 with early RSV recover faster than receiving no antiviral treatment.
-
Examining the impact of COVID-19 on RSV-related emergency visits in children
This study looks at how COVID-19 affected emergency visits for bronchiolitis and RSV in young children to see what might happen as restrictions ease.
Related topics
Quick answers
How many Respiratory Syncytial Virus clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United Kingdom (2 trials), Australia (1 trial), South Korea (1 trial), China (1 trial), Laos (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.